Financials data is unavailable for this security.
View more
Year on year Novozymes A/S had net income fall -24.68% from 405.98m to 305.80m despite a 59.53% increase in revenues from 2.40bn to 3.83bn. An increase in the cost of goods sold as a percentage of sales from 45.68% to 52.80% was a component in the falling net income despite rising revenues.
| Gross margin | -- |
|---|---|
| Net profit margin | -- |
| Operating margin | -- |
| Return on assets | -- |
|---|---|
| Return on equity | -- |
| Return on investment | -- |
More ▼
Cash flow in EURView more
In 2024, Novozymes A/S increased its cash reserves by 87.04%, or 130.30m. The company earned 1.02bn from its operations for a Cash Flow Margin of 26.60%. In addition the company used 199.70m on investing activities and also paid 703.20m in financing cash flows.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 172.33 |
|---|---|
| Tangible book value per share | -6.87 |
More ▼
Balance sheet in EURView more
| Current ratio | 1.61 |
|---|---|
| Quick ratio | 1.00 |
| Total debt/total equity | 0.2892 |
|---|---|
| Total debt/total capital | 0.2244 |
More ▼
Growth rates in EUR
SmartText is unavailable
| Div yield(5 year avg) | 1.44% |
|---|---|
| Div growth rate (5 year) | 3.41% |
| Payout ratio (TTM) | -- |
| EPS growth(5 years) | -14.71 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -- |
More ▼
